BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Policy

  FDA Panel Rejects Merck & Co., Inc. Respiratory Pill Singulair For Over-The-Counter Use

  May 5, 2014

   · 

  1 min read
• Job Trends

  AEterna Zentaris Expands Operations To U.S. And Creates R&D Jobs

  May 5, 2014

   · 

  4 min read
• Job Trends

  Teva Pharmaceutical Industries Limited To Speed Up Cost-Cutting Plans, Layoffs And Facility Shutdowns On The Horizon

  May 5, 2014

   · 

  1 min read
• Deals

  San Diego’s Ambrx, Inc. Files For $86 Million IPO To Advance Antibody-Drug Conjugates

  May 5, 2014

   · 

  1 min read
• FDA

  FDA Clears QIAGEN Inc.'s QIAsymphony RGQ MDx System For C. Difficile

  May 5, 2014

   · 

  2 min read
• Ranbaxy Laboratories Recalls Nearly 30,000 Packs Of Allergy-Relief Drug In U.S.

  May 5, 2014

   · 

  1 min read
• Deals

  Abbott Laboratories Taps Morgan Stanley To Help Sell Established Drugs

  May 5, 2014

   · 

  1 min read
• FDA

  Alexion Pharmaceuticals Inc. Wins FDA Approval Of Soliris® Accelerated Approval To Regular Approval

  May 5, 2014

   · 

  17 min read
• Biotech Beach

  Ruthigen Announces Partial Exercise Of Underwriters’ Option To Purchase Additional Shares

  May 5, 2014

   · 

  2 min read
• Business

  ANI Pharmaceuticals, Inc. Reports Record Net Revenues Of $10.9 Million, EPS Of $0.33, And Adjusted Non-GAAP EBITDA Of $4.2 Million For The First Quarter Ended March 31, 2014

  May 5, 2014

   · 

  1 min read